Merck KGaA

Sarizotan in Parkinson Patients With L-Dopa-Induced Dyskinesia

31 May 2009

The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship ...

Latest Discussions

MJFF Closed Next Week
Members in the News: Charleen T. Chu Receives Outstanding Investigator Award

Responses: 1
Cognitive Problems May Precede PD Motor Symptoms

Responses: 1
Systems Approaches to Parkinson's Disease

Responses: 15
Federal Funding of Embryonic Stem Cells Halted

Responses: 1

MJFF Closed Next Week

27 Aug 2010

MJFF is closed next week, but news will be back up after Labor Day! ...
Gila Monster Venom Trial to Treat PD Underway in U.K.

27 Aug 2010

Researchers at University College London Hospitals (U.K.) are starting a clinical trial to test Exenatide, a synthetic version of a compound originally found in Gila monster saliva. MJFF has funded ...
NIH Director Collins Speaks about Stem Cell Ruling

26 Aug 2010

According to an article in The Scientist, NIH Director Francis Collins says that he was "stunned" by the recent ruling halting research on embryonic stem cells. ...
Members in the News: Charleen T. Chu Receives Outstanding Investigator Award

26 Aug 2010

The American Society for Investigative Pathology has given Charleen T. Chu, associate professor at the University of Pittsburgh, their Outstanding Investigator Award. In a recent paper published in ...

EMBO/EMBL Symposium: Structure and Function of Neural Circuits

05 Sep 2010 - 08 Sep 2010
Autophagy: From Molecules to Disease

08 Sep 2010 - 12 Sep 2010
2010 World Molecular Imaging Congress

08 Sep 2010 - 11 Sep 2010

RFP: Novel Biomarkers to Accelerate Drug Discovery for Frontotemporal Dementias

Institution: The Association for Frontotemporal Dementias

Submission deadline: 09 Sep 2010
2011 NIH Director’s Pioneer Award Program (DP1)

Institution: National Institutes of Health (NIH)

Submission deadline: 13 Sep 2010
Clinical and Basic Research: Parkinson's Disease and Dystonia

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010
Dekker RFP: Clinical Aspects of Parkinson's Disease

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010
Dystonia RFP

Institution: The Bachmann-Strauss Dystonia & Parkinson Foundation

Submission deadline: 13 Sep 2010

Merck KGaA

Latest Discussions

Latest News

Upcoming Events

Funding Opportunities